You are here
Use of controlled drugs
We lead the Controlled Drugs National Group.
We have established four sub-groups to focus on the key areas of thefts and frauds (vigilance), patient safety, policy and operational issues and prescription monitoring. These four groups comprise membership from key regulators and agencies, pharmacists and controlled drug accountable officers (CDAOs). They will produce quarterly newsletters to report on their findings and signpost guidance.
The four sub groups are (open headings to see newsletters):
Patient safety sub-group (formerly the clinical sub-group)
Guidance co-produced with NHS England Patient Safety Team giving details of safety incidents and checklists for safer use of:
Fentanyl and buprenorphine transdermal patches:
Oral oxycodone medicines:
MS syringe drivers:
Policy and operational issues sub-group
Prescription monitoring sub-group
No newsletter issued yet
- Last updated:
- 5 May 2017